SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-084764
Filing Date
2022-08-01
Accepted
2022-08-01 17:02:13
Documents
1
Period of Report
2022-07-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2222147-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2222147-4_4seq1.xml 4 5940
  Complete submission text file 0001104659-22-084764.txt   7293
Mailing Address C/O RESTORBIO, INC. 500 BOYLSTON ST., 12TH FLOOR BOSTON MA 02116
Business Address
Grissinger Michael (Reporting) CIK: 0001757601 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 221125604

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations